红日药业：公司会积极、务实、审慎地回复投资者提问

Group 1 - The core viewpoint of the article is that Hongri Pharmaceutical (300026) emphasizes the importance of maintaining a serious and responsible communication platform for investors through the Interactive Easy platform [1] - The company actively and prudently responds to investor inquiries, ensuring that the information shared is accurate and beneficial to shareholders [1] - Hongri Pharmaceutical is cautious in identifying and handling questions that may spread misinformation or mislead small investors, aiming to protect shareholder interests [1]